Senate Bill 296 would provide the U.S. Food and Drug Administration (FDA) with tools to better manage and hopefully prevent shortages of life-saving medications. This legislation enables the FDA to work more effectively with the pharmaceutical supply chain to ensure drug availability, and enhances the agency's ability to monitor drugs that are vulnerable to shortages in the future. The legislation also enables FDA to work with drug manufacturers to establish contingency plans for manufacturing interruptions, such as raw material shortages, adjustments to production capabilities and product discontinuations.
ASHP supports the Preserving Access to Life Saving Medications Act (S. 296) cosponsored by Sens. Klobuchar and Casey. Drug shortages in hospitals and health systems cause significant disruptions in patient care. The medications affected are often life saving drugs as well as medications used to relieve pain, to treat serious infections, and other conditions.